5AM Venture Management, LLC Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001799883

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q3 2026 · 15 positions · Total reported value $297.01M · Top-10 concentration 93.7% · Updated 2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

Turnover: 43.8% · 0 new · 6 cut · 1 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -23.4% · vs SPY -25.5% · Prev Value $287.89M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -24.1% · vs SPY -26.3% · Latest Value $297.01M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, 5AM Venture Management, LLC disclosed 15 equity positions with a combined reported value of $297.01M. The filing implies a focused portfolio: its ten largest positions account for 93.7% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were ARTV ($139.10M), TRDA ($24.03M), TYRA ($22.51M). By sector, the heaviest allocations are Health Care 98.8%, Industrials 1.2%. Versus the prior quarter, allocation shifted toward Health Care (+4.1pp) and away from Industrials (-4.1pp).

Versus the prior quarter, 5AM Venture Management, LLC opened 0 new positions, trimmed 6 and fully exited 1, a turnover rate of 43.8% of positions. The portfolio's overlap with the prior quarter was 94% of names.

Of the 1 positions fully exited versus the prior quarter, the largest were SRZN ($7.04M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

No new positions this quarter.

Fully Exited (vs previous quarter)

  • SRZN SURROZEN INC · prev qtr: $7.04M

Insider Transactions (Form 4)

Latest 5AM Venture Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

5AM Venture Management, LLC is an SEC-registered 13F filer based in San Francisco, CA, United States. As of Q3 2026 it reported 15 US equity positions with a combined value of $297.01M. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: SAN FRANCISCO, CA, United States
  • SEC registration: 801-120173 (status: Approved), registered 2021-01-19
  • Regulatory AUM (Form ADV): $1.08B as of 2026-03-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 12 private funds, of which 1 hedge funds
  • Website: 5amventures.com

Portfolio Structure

  • 15 positions · $297.01M reported value (Q3 2026)
  • Top 10 holdings = 93.7% of reported value
  • Largest position: ARTV (ARTIVA BIOTHERAPEUTICS INC) at 46.8%
  • Average position size: $19.80M

Sector Tilt

  • Health Care 98.8%
  • Industrials 1.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 1 added, 6 reduced, 1 exited
  • 8 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: Aggressive rotation into ARTV (311% share increase) while reducing most other positions, suggesting high conviction in ARTIVA’s potential and broader biotech caution. 2. Key moves: - Added: ARTV (46.83% weight, +311.3% shares). - Reduced: TRDA (-6.7% shares), CAMP (-10.1%), PHVS (-39.8%), CLDX (-15.1%), MPLT (-21.9%). 3. Portfolio structure: Active, concentrated (15 positions), heavily Health Care (100%) with high-risk appetite (small-cap biotech focus). 4. Per-holding one-liner: - ARTV: ARTIVA Biopharmaceuticals (unverified: gene therapy?). - TRDA: Entrada Therapeutics (unverified: protein degraders). - TYRA: Tyra Biosciences (unverified: kinase inhibitors). - CAMP: CAMP4 Therapeutics (unverified: RNA therapeutics). - PHVS: Pharvaris N.V. (unverified: C1 esterase inhibitors). - TECX: Tectonic Therapeutic (unverified: PROTACs). - CLDX: Celldex Therapeutics (unverified: cancer immunotherapy). - ZNTL: Zentalis Pharmaceuticals (unverified: oncology). - BHVN: Biohaven (unverified: migraine/CGRP). - MPLT: Maplight Therapeutics (unverified: epigenetics). 5. Style summary: High-conviction, concentrated biotech play with aggressive bets on clinical-stage therapeutics.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 13:15

Sector Allocation

Health Care 98.8%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 9.68M $139.10M 46.83%
46.83%
Add
2 3.78M $24.03M 8.09%
8.09%
Reduce
3 1.03M $22.51M 7.58%
7.58%
Hold
4 5.28M $21.32M 7.18%
7.18%
Reduce
5 479.90K $15.22M 5.12%
5.12%
Reduce
6 606.66K $14.13M 4.76%
4.76%
Hold
7 422.27K $13.69M 4.61%
4.61%
Reduce
8 3.95M $10.94M 3.68%
3.68%
Hold
9 738.97K $9.87M 3.32%
3.32%
Hold
10 741.89K $7.56M 2.54%
2.54%
Reduce
11 476.20K $5.20M 1.75%
1.75%
Hold
12 3.06M $4.25M 1.43%
1.43%
Hold
13 1.37M $4.18M 1.41%
1.41%
Hold
14 1.05M $3.43M 1.16%
1.16%
Hold
15 981.27K $1.58M 0.53%
0.53%
Reduce

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 90% R 90% F1 90% (modelled on 2026-Q2; 9/10 hit)

Low-confidence forecast This fund replaces about 25% of its Top-10 each quarter and backtests at F1 76% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (11 quarters)

Avg precision 76% · recall 76% · F1 76% · avg rank error 2.5 · Top-10 turnover 25%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 70% 70% 70% ELVN · TRDA · PHVS · CLDX · MLTX · BHVN · IRON · DNTH · MRUS · VOR ELVN · TRDA · DNTH · MRUS · CLDX · PRAX · VKTX · PHVS · BHVN · RNAM
2024-Q2 70% 70% 70% ELVN · TRDA · DNTH · MRUS · CLDX · PRAX · PHVS · VKTX · TYRA · RNAM SKYE · TRDA · ELVN · DNTH · CLDX · BHVN · TYRA · PHVS · PRAX · ERAS
2024-Q3 70% 70% 70% SKYE · TRDA · ELVN · DNTH · CLDX · BHVN · TYRA · PHVS · PRAX · ERAS TRDA · ELVN · SKYE · ARTV · DNTH · BHVN · TYRA · CNTA · TECX · PRAX
2024-Q4 70% 70% 70% TRDA · ELVN · SKYE · ARTV · DNTH · BHVN · TYRA · CNTA · TECX · PRAX TRDA · ELVN · SKYE · TECX · ARTV · DNTH · BHVN · PHVS · MLTX · CAMP
2025-Q1 80% 80% 80% TRDA · ELVN · SKYE · TECX · ARTV · DNTH · BHVN · MLTX · PHVS · CAMP TRDA · ELVN · DNTH · SKYE · PHVS · CNTA · CAMP · BHVN · MLTX · VRDN
2025-Q2 80% 80% 80% TRDA · ELVN · DNTH · SKYE · PHVS · CAMP · BHVN · CNTA · MLTX · VRDN SKYE · TRDA · DNTH · ELVN · PHVS · MLTX · CNTA · VOR · VRDN · TECX
2025-Q3 70% 70% 70% SKYE · TRDA · DNTH · ELVN · PHVS · MLTX · CNTA · VRDN · VOR · CLDX SKYE · TRDA · PHVS · CAMP · CNTA · VRDN · ELVN · EYPT · DNTH · TYRA
2025-Q4 70% 70% 70% SKYE · TRDA · PHVS · CAMP · CNTA · VRDN · ELVN · EYPT · DNTH · TYRA TRDA · CAMP · TYRA · VRDN · PHVS · ERAS · EYPT · MPLT · CNTA · CLDX
2026-Q1 80% 80% 80% TRDA · CAMP · TYRA · VRDN · PHVS · ERAS · EYPT · MPLT · CNTA · CLDX ERAS · TRDA · TYRA · CAMP · CNTA · PHVS · MPLT · TECX · CLDX · ARTV
2026-Q2 80% 80% 80% ERAS · TRDA · TYRA · CAMP · CNTA · PHVS · MPLT · TECX · CLDX · ARTV MPLT · TYRA · TRDA · PHVS · CAMP · ARTV · TECX · ZNTL · CLDX · EYPT
2026-Q3 ★ 90% 90% 90% MPLT · TYRA · TRDA · PHVS · CAMP · ARTV · TECX · ZNTL · CLDX · EYPT ARTV · TRDA · TYRA · CAMP · PHVS · TECX · CLDX · ZNTL · BHVN · MPLT

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

FAQ

What did 5AM Venture Management, LLC buy in 2026-Q3?

In its 2026-Q3 13F filing, 5AM Venture Management, LLC reported 15 equity positions worth $297.01M in aggregate; its largest disclosed positions were ARTV ($139.10M), TRDA ($24.03M), TYRA ($22.51M).

How large is 5AM Venture Management, LLC's portfolio?

5AM Venture Management, LLC reported $297.01M of long equity holdings across 15 positions as of 2026-Q3. Top-10 holdings account for 93.7% of reported value.

What is 5AM Venture Management, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/5am-venture-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →